AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Linsita M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Lincoln Pharmaceuticals Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Linsita M 50mg/500mg Tablet

DiabetaComb 50mg/500mg tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent severe diabetic complications like vision impairment and kidney disease, potentially lowering heart attack and stroke risks. DiabetaComb 50mg/500mg may be used independently or in conjunction with other diabetes treatments. Optimal results require a healthy diet and regular physical activity. Dosage is personalized based on your health status, glucose levels, and other medications. Taking it with food minimizes stomach upset. Consistent daily dosing at the same time maximizes effectiveness; discontinuation should only occur under physician guidance. Adherence to your prescribed diet and exercise plan is crucial for diabetes control, as lifestyle significantly impacts management. Common side effects include nausea, diarrhea, vomiting, indigestion, headache, and sore throat. Hypoglycemia is a potential side effect, particularly when combined with insulin or sulfonylureas; learn to recognize and manage this. This medication isn't suitable for everyone. Inform your doctor of any pre-existing kidney, liver, heart, or pancreatic conditions, or significant alcohol consumption before starting. Pregnant or breastfeeding individuals require prior physician consultation. Interactions with other medications are possible; disclose all medications to ensure safety. Alcohol should be minimized due to its hypoglycemic effects. Your doctor will monitor kidney function and blood sugar levels throughout your treatment.

Uses of Linsita M 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Linsita M 50mg/500mg Tablet:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Linsita M 50mg/500mg Tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.

Common Side effects of Linsita M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Linsita M 50mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Linsita M 50mg/500mg Tablets should be administered with a meal.

How Linsita M 50mg/500mg Tablet works:

Linsita M 50mg/500mg tablets combine sitagliptin and metformin to manage blood glucose levels. Sitagliptin boosts insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action leads to more effective blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Linsita M 50mg/500mg tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Linsita M 50mg/500mg Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against possible risks prior to prescribing this medication. Medical advice should be sought.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Based on limited available data in humans, the use of Linsita M 50mg/500mg tablets while breastfeeding is likely inadvisable due to the potential for the medication to transfer to breast milk and pose a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Linsita M 50mg/500mg tablets, potentially requiring dosage modification. Consultation with a physician is recommended. Linsita M 50mg/500mg tablets are contraindicated in patients with severe renal disease. Routine monitoring of renal function is advised during treatment.

LiverLiverUNSAFE

Patients with liver conditions should likely refrain from using Linsita M 50mg/500mg Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Linsita M 50mg/500mg Tablet :

Should you forget a dose of Linsita M 50mg/500mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Linsita M 50mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Linsita M 50mg/500mg Tablet

Linsita M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged use of Linsita M 50mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Linsita M 50mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Linsita M 50mg/500mg Tablets are contraindicated in patients with known allergies to any component or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Linsita M 50mg/500mg Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Linsita M 50mg/500mg tablets can cause lactic acidosis (MALA), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect, more common in patients with kidney disease, the elderly, or those who consume significant alcohol, should be avoided. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Linsita M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Linsita M 50mg/500mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Linsita M 50mg/500mg Tablets are contraindicated in patients with known allergies to any component or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Linsita M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Linsita M 50mg/500mg tablets can cause lactic acidosis (MALA), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol, so its use is avoided in such individuals. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Linsita M and seek immediate medical attention.
Prolonged use of Linsita M 50mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, yearly supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Linsita M 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Linsita M 50mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Linsita M 50mg/500mg Tablets are contraindicated in patients with known allergies to any of its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Linsita M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Linsita M 50mg/500mg tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Linsita M 50mg/500mg tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Linsita M 50mg/500mg Tabl...
103
MRP 120
14% off